Basic Science, biomarkers, new diagnostics and translational research
Invited discussant abstracts 483PD, 484PD, 485PD and 486PD
Date
21 Dec 2015Session
Basic Science, biomarkers, new diagnostics and translational researchPresenters
Kenneth O'ByrneAuthors
K. O'ByrneAuthor affiliations
- St. James's Hospital, 10 - Brisbane/AU
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
View the abstracts discussed:
- The declaration of new lesions as a major factor of local-central discrepancy during a RECIST phase II trial
- A multicenter prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung cancer
- Genetic variation in immune genes and prognosis of locoregionally advanced nasopharyngeal carcinoma
- MicroRNA-125b functions as a key arbitrator for Mucin1 expressing breast cancer stem-like cells proliferation, migration and drug resistance
Resources from the same session
437 - The tumor vascularity and lipiodol deposition predicts risk of disease progression after TACE in patients with unresectable HCC
Presenter: Cheng-Shi Chen
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract
825 - Clinical impact of a pre-screening system using comprehensive genomic profiling to guide phase I trial registry in patients with advanced solid tumors
Presenter: Hitomi Okuma
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract
1184 - Molecular epidemiology study of PD-L1 expression in patients (pts) with EGFR-mutant NSCLC
Presenter: Jongho Cho
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract
Slides
Webcast
Invited discussant abstract 357O
Presenter: Hyun Cheol Chung
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Slides
Webcast
Invited discussant abstract 26O
Presenter: Keith Kerr
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Slides
Webcast
479 - The declaration of new lesions as a major factor of local-central discrepancy during a RECIST phase II trial
Presenter: Hubert Beaumont
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract
681 - A multicenter prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung cancer
Presenter: Eiji Iwama
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract
1183 - Genetic variation in immune genes and prognosis of locoregionally advanced nasopharyngeal carcinoma
Presenter: Huai Liu
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract
1057 - MicroRNA-125b functions as a key arbitrator for Mucin1 expressing breast cancer stem-like cells proliferation, migration and drug resistance
Presenter: MADHULIKA Singh
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract
1045 - A high throughput compound screen identifies potential combinations to overcome resistance to Cdk2 inhibitors in Cyclin E1 amplified high grade serous ovarian cancer
Presenter: George Au-Yeung
Session: Basic Science, biomarkers, new diagnostics and translational research
Resources:
Abstract